Acute Renal Failure (ARF) (Acute Kidney Injury) Market Insights, Epidemiology, and Market Forecast 2030 by DelveInsight

DelveInsight Business Research LLP

DelveInsight's "Acute Renal Failure (ARF) (Acute Kidney Injury) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Acute Renal Failure (ARF) (Acute Kidney Injury), historical and forecasted epidemiology as well as the Acute Renal Failure (ARF) (Acute Kidney Injury) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight launched a new report on Acute Renal Failure Market Insights, Epidemiology, and Market Forecast 2030.

DelveInsight's "Acute Renal Failure (ARF) (Acute Kidney Injury) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Acute Renal Failure (ARF) (Acute Kidney Injury), historical and forecasted epidemiology as well as the Acute Renal Failure (ARF) (Acute Kidney Injury) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Acute Renal Failure, which is now known as Acute Kidney Injury is characterized by azotemia that progresses over several hours or days, with or without oliguria. ARF is commonly defined as an abrupt decline in renal function, clinically manifesting as a reversible acute increase in nitrogen waste products measured by blood urea nitrogen (BUN) and serum creatinine levels over the course of hours to weeks. The disease leads to an abrupt loss of kidney function, leading to the retention of waste products, electrolyte disturbances, and volume status changes. 

Request for sample pages: https://www.delveinsight.com/sample-request/acute-renal-failure-arf-acute-kidney-injury-market

Acute kidney injury (AKI) is a sudden episode of kidney failure or kidney damage that happens within a few hours or a few days. AKI causes a build-up of waste products in your blood and makes it hard for your kidneys to keep the right balance of fluid in your body.

Robust pipeline with a novel mechanism of action and increasing incidence are major market drivers of Acute Kidney Injury market. Additionally, the Acute Kidney Injury pipeline is also expected to change the current dynamics of market which presently comprises of Biologics and molecules with new mechanisms of action.

The risk factors associated with AKI include age, exposure to nephrotoxins, family history, race and ethnicity, gender and other factors.

 

Of the emerging therapies for AKI, the key players include ANG-3777 (BB3; Angion Biomedica), QPI1002 (Quark Pharmaceutical), ASP1128 (Astellas Pharma), MB-102 (MediBeacon), Ruconest (Conestat alfa; PharmingTechnologies), recAP (AM Pharma), bRESCAP (Alloksys), EA-230 (Exponential Biotherapies) and Simdax (Levosimendan; Orion Pharma). 

Click here and get access to free sample pages.

Scope of the Report

• The report covers the descriptive overview of Acute Renal Failure (ARF) (Acute Kidney Injury)
• Comprehensive insight has been provided into the Acute Renal Failure (ARF) (Acute Kidney Injury) epidemiology and treatment in the 7MM
• An all-inclusive account of both the current and emerging therapies for Acute Renal Failure (ARF) (Acute Kidney Injury) are provided
• A detailed review of Acute Renal Failure (ARF) (Acute Kidney Injury) market; historical and forecasted
• The report provides an edge while developing business strategies

Table of contents:

1 Key Insight
2 Executive Summary of Acute Renal Failure
3 Acute Renal Failure Market Overview at a Glance
4 Disease Background and Overview: Acute Renal Failure
5 Case Reports
6 Acute Renal Failure Epidemiology and Patient Population
7 United States Epidemiology
8 EU5 Epidemiology
9 Japan Epidemiology
10 Current Acute Renal Failure Treatment and Medical Practices
11 Unmet needs
12 Acute Renal Failure Marketed Drugs
13 Acute Renal Failure Emerging Drugs
14 Acute Renal Failure 7MM Market Analysis
15 United States
16 EU-5 countries: Market Outlook
17 Japan Market Outlook
18 Acute Renal Failure Market Drivers
19 Acute Renal Failure Market Barriers
20 SWOT Analysis
21 Reimbursement and market access
22 Appendix
23 DelveInsight Capabilities
24 Disclaimer
25 About DelveInsight

Download report: https://www.delveinsight.com/report-store/acute-renal-failure-arf-acute-kidney-injury-market

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/